Mendus AB (publ) (STO:IMMU)
Sweden · Delayed Price · Currency is SEK 4.010
-0.195 (-4.64%)
Mar 23, 2026, 5:16 PM CET
Mendus AB Market Cap
Mendus AB has a market cap or net worth of 257.97 million as of March 23, 2026. Its market cap has decreased by -31.66% in one year.
Market Cap
257.97M
Enterprise Value
212.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.01
Market Cap Chart
Since April 22, 2013, Mendus AB's market cap has increased from 117.09M to 257.97M, an increase of 120.32%. That is a compound annual growth rate of 6.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 257.97M | -24.77% |
| Dec 30, 2025 | 342.91M | -12.71% |
| Dec 30, 2024 | 392.86M | -12.97% |
| Dec 29, 2023 | 451.43M | -6.06% |
| Dec 30, 2022 | 480.56M | -43.76% |
| Dec 30, 2021 | 854.43M | -30.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascelia Pharma AB | 374.90M |
| Bio-Works Technologies AB | 314.18M |
| Intervacc AB | 312.18M |
| Elicera Therapeutics AB | 256.27M |
| Sprint Bioscience AB | 215.25M |
| Isofol Medical AB | 204.93M |
| Initiator Pharma | 202.62M |
| AlzeCure Pharma AB | 194.78M |